According to previous research, hsa-mir-210 can directly target HIF-1 α and inhibit the HIF-1 α pathway by participating in the molecular response of hypoxic kidney injury in vitro, thus protecting renal tumor cells from hypoxia-induced apoptosis (Liu et al., 2017). The gene discussed is SETD2; the disease is kidney neoplasm.